Gene · 6844
Papers2,700
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,700
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Silica-coated magnetic nanoparticles activate microglia and induce neurotoxic D-serine secretion. | Part Fibre Toxicol | 2021 | 34384435 | PubTator, text mining | PubMed |
| Identification of Novel Insulin Resistance Related ceRNA Network in T2DM and Its Potential Editing by CRISPR/Cas9. | Int J Mol Sci | 2021 | 34360895 | PubTator, text mining | PubMed |
| CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting. | Cells | 2021 | 34360006 | PubTator, text mining | PubMed |
| Bemisia tabaci Vesicle-Associated Membrane Protein 2 Interacts with Begomoviruses and Plays a Role in Virus Acquisition. | Cells | 2021 | 34359870 | PubTator, text mining | PubMed |
| Reelin Alleviates Mesenchymal Stem Cell Senescence and Reduces Pathological α-Synuclein Expression in an In Vitro Model of Parkinson's Disease. | Genes (Basel) | 2021 | 34356083 | PubTator, text mining | PubMed |
| Membrane Binding of α-Synuclein Stimulates Expansion of SNARE-Dependent Fusion Pore. | Front Cell Dev Biol | 2021 | 34350173 | PubTator, text mining | PubMed |
| Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons. | Stem Cell Reports | 2021 | 34329596 | PubTator, text mining | PubMed |
| Systematic Profiling of mRNA Splicing Reveals the Prognostic Predictor and Potential Therapeutic Target for Glioblastoma Multiforme. | J Oncol | 2021 | 34326872 | PubTator, text mining | PubMed |
| Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease. | NPJ Parkinsons Dis | 2021 | 34312398 | PubTator, text mining | PubMed |
| Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod. | Front Mol Neurosci | 2021 | 34305524 | PubTator, text mining | PubMed |
| Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice. | Int J Mol Sci | 2021 | 34299000 | PubTator, text mining | PubMed |
| Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia. | Mol Neurodegener | 2021 | 34266459 | PubTator, text mining | PubMed |
| Clinical Relevance of PD-L1 Expression and CD8+ T Cells' Infiltration in Patients With Lung Invasive Mucinous Adenocarcinoma. | Front Oncol | 2021 | 34249733 | PubTator, text mining | PubMed |
| Effects of venoms on neutrophil respiratory burst: a major inflammatory function. | J Venom Anim Toxins Incl Trop Dis | 2021 | 34249119 | PubTator, text mining | PubMed |
| Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders. | Front Aging Neurosci | 2021 | 34248606 | PubTator, text mining | PubMed |
| Editorial: Neuroscience and Neurotechnology of Neuronal Cell Surface Molecules in Neural Circuits. | Front Neural Circuits | 2021 | 34248506 | PubTator, text mining | PubMed |
| Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning. | Alzheimers Res Ther | 2021 | 34243793 | PubTator, text mining | PubMed |
| Targeting Small GTPases and Their Prenylation in Diabetes Mellitus. | J Med Chem | 2021 | 34236862 | PubTator, text mining | PubMed |
| Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis. | EMBO J | 2021 | 34232536 | PubTator, text mining | PubMed |
Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR-383-5p/vesicle-associated membrane protein-2 axis. | Pharmacol Res Perspect | 2021 | 34223709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6844/papers?page=32